Australian earnings preview – A2 Milk


Full Year:

The A2 Milk Company Limited (A2M) produces and supplies milk and milk-related dairy products in Australia, New Zealand, U.S, China, Korea, and the United Kingdom. A2 Milk holds the mantle as the only fresh cows’ milk to contain the A2 and A1 proteins, which sets it apart from some of its competitors in the dairy market. A2 Milk is dual-listed in Australia and New Zealand and reports its full-year numbers on the 19th of August.

A2 Milk has been a beneficiary of the crisis unleashed by the COVID-19 pandemic. A2 Milk sales surged during the initial wave of panic buying and it has continued to experience strong demand and win market share. In response, A2 Milk upgraded its full-year earnings guidance in April 2020 by 32%.

Ironically, a delay in planned recruitment due to COVID-19 restrictions, currency movements, and lower costs for staff travel has also contributed to increased underlying earnings. Revenue for the year is tipped to be in the range of $1.7 billion to $1.75 billion.

After making a fresh all-time high in June of this year at $20.05 the A2M share price has spent the past two months consolidating, reflecting the strong fundamentals outlined above.

It’s hard not to like this stock with the main short term risk to the uptrend being a “buy the rumour sell the fact” type reaction after it reports it’s full-year numbers next week. In this instance, we would look to buy dips back towards support $17.70/50, looking for a break above $20.05.

Australian earnings preview – A2 Milk

Source Tradingview. The figures stated areas of the 13th of August 2020. Past performance is not a reliable indicator of future performance.  This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.